Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
62.90
-0.60 (-0.94%)
At close: Mar 13, 2026
TPE:1720 Market Cap
TPE:1720 has a market cap or net worth of 11.24 billion as of March 13, 2026. Its market cap has increased by 1.45% in one year.
Market Cap
11.24B
Enterprise Value
12.97B
Revenue
7.02B
Ranking
n/a
PE Ratio
12.14
Stock Price
62.90
Market Cap Chart
Since March 4, 1996, TPE:1720's market cap has increased from 2.29B to 11.24B, an increase of 389.97%. That is a compound annual growth rate of 5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 11.24B | 6.79% |
| Dec 31, 2025 | 10.53B | -4.85% |
| Dec 31, 2024 | 11.06B | -6.07% |
| Dec 29, 2023 | 11.78B | 7.15% |
| Dec 30, 2022 | 10.99B | 42.69% |
| Dec 30, 2021 | 7.70B | 14.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTY Biopharm Company | 20.31B |
| Grape King Bio | 17.78B |
| ScinoPharm Taiwan | 16.37B |
| Synmosa Biopharma | 15.57B |
| YungShin Global Holding | 14.09B |
| Foresee Pharmaceuticals | 12.62B |
| Alar Pharmaceuticals | 12.49B |
| Handa Pharmaceuticals | 12.10B |